TP53 and hepatocellular carcinoma: The anti-depressant sertraline, as an antagonist targeting CDC7, selectively induces senescence of the TP53-mutant-bearing HCC cells and promotes the apoptosis of senescent HCC cells when combined with the mTOR inhibitor, leading to reduced HCC growth in the mouse model [108].